05:04 PM EST, 11/12/2024 (MT Newswires) -- Samuel C. Blackman, Head of R&D, on November 08, 2024, sold 28,255 shares in Day One Biopharmaceuticals ( DAWN ) for $456,223. Following the Form 4 filing with the SEC, Blackman has control over a total of 2,057,535 shares of the company, with 1,057,535 shares held directly and 1,000,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1845337/000141588924026624/xslF345X05/form4-11122024_091151.xml

Price: 14.78, Change: +0.13, Percent Change: +0.89